ARTICLE | Company News
VGX, National Institutes of Health infectious news
October 6, 2008 7:00 AM UTC
VGX received a seven-year contract for up to $23.5 million from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop Pennvax-G, a DNA vaccine against HIV clades A, C, and D,...